Update On VIRL Invading PWRM’s areas of research

June 24, 2010 - PRLog -- PWRM is now available for $.04 cents a share. Since the beginning of June 2010 PWRM has been trading in a channel. Pay attention for a possible breakout. A breakout could be an indicator of possible momentum.




Two of Power3 Medical Areas of Research

Breast Cancer

Power3’s early indication breast cancer NAF protein footprint test
More than 120 identified NAF protein biomarkers and drug targets for early indication and treatment of breast cancer
NAF footprints for individualized therapy



Neurodegenerative Diseases - ALS (Lou Gehrig’s Disease), Alzheimer’s Disease, Parkinson’s Disease, Other Neurological Disorders

Power3’s blood serum test for distinguishing between the neurodegenerative diseases
Blood serum biomarkers and drug targets for neurodegenerative disease





Continue your research at www.power3medical.com

____________________________

Virage Logic Corporation (NasdaqGM: VIRL)



VIRL way up today on news of acquisition by Synopsys.

Last: $11.88

Chg: +0.01(+0.08%)

Vol: 381,729

Read the entire story Synopsys buys some assets of private chip technology co

About VIRL:

Virage Logic’s highly differentiated product portfolio includes processor solutions, interface IP solutions, embedded SRAMs and NVMs, embedded test and yield optimization solutions, logic libraries, and memory development software. As the semiconductor industry’s trusted IP partner, more than 400 foundry, IDM and fabless customers rely on Virage Logic to achieve higher performance, lower power, higher density and optimal yield, as well as shorten time-to-market and time-to-volume.

Visit: http://www.viragelogic.com

Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and received an additional 1,000,000 shares 144 restricted stocks for a continuation of 6 months of advertisement and disseminating news, as well as $15,000 dollars for IR services for Power 3 Medical Products Inc. (PWRM.OB). Recently, Crown Equity Holdings, Inc has received an additional amount of 2,000,000 shares of free trading stock for 60 days media advertisement, web design and maintenance for Power 3 Medical Products Inc. (PWRM.OB)

*******************************************
Sign-Up For Free Stock Alerts At http://crwepicks.com/signup
*******************************************











THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.StockHotTips.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations.


*******************************************